{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:22:31Z","timestamp":1791832951880,"version":"4.3.4"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201400058C"],"award-info":[{"award-number":["HHSN272201400058C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI119056"],"award-info":[{"award-number":["R01 AI119056"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>\n                    The development of vaccines against flaviviruses, including Zika virus (ZIKV) and dengue virus (DENV), continues to be a major challenge, hindered by the lack of efficient and reliable methods for screening neutralizing activity of sera or antibodies. To address this need, we previously developed a plasmid-based, replication-incompetent DENV reporter virus particle (RVP) production system as an efficient and safe alternative to the Plaque Reduction Neutralization Test (PRNT). As part of the response to the 2015\u20132016 ZIKV outbreak, we developed pseudo-infectious ZIKV RVPs by modifying our DENV RVP system. The use of ZIKV RVPs as critical reagents in human clinical trials requires their further validation using stability and reproducibility metrics for large-scale applications. In the current study, we validated ZIKV RVPs using infectivity, neutralization, and enhancement assays with monoclonal antibodies (MAbs) and human ZIKV-positive patient serum. ZIKV RVPs are antigenically equivalent to live virus based on binding ELISA and neutralization results and are nonreplicating based on the results of live virus replication assays. We demonstrate reproducible neutralization titer data (NT\n                    <jats:sub>50<\/jats:sub>\n                    values) across different RVP production lots, volumes, time frames, and laboratories. We also show RVP stability across experimentally relevant time intervals and temperatures. Our results demonstrate that ZIKV RVPs provide a safe, high-throughput, and reproducible reagent for large-scale, long-term studies of neutralizing antibodies and sera, which can facilitate large-scale screening and epidemiological studies to help expedite ZIKV vaccine development.\n                  <\/jats:p>","DOI":"10.1371\/journal.pntd.0008730","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T13:32:39Z","timestamp":1605706359000},"page":"e0008730","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antigenicity, stability, and reproducibility of Zika reporter virus particles\u00a0for long-term applications"],"prefix":"10.1371","volume":"14","author":[{"given":"J. Charles","family":"Whitbeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Kadash-Edmondson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"Grinyo-Escuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis J.","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9254-4942","authenticated-orcid":true,"given":"Celine","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant C.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5530-9943","authenticated-orcid":true,"given":"Frederick W.","family":"Holtsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Javad","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3333-2314","authenticated-orcid":true,"given":"Edgar","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8245-3083","authenticated-orcid":true,"given":"Benjamin J.","family":"Doranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"issue":"5","key":"pntd.0008730.ref001","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. Isolations and serological specificity","volume":"46","author":"GW Dick","year":"1952","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"9990","key":"pntd.0008730.ref002","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0140-6736(15)61273-9","article-title":"Zika virus: following the path of dengue and chikungunya?","volume":"386","author":"D Musso","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"pntd.0008730.ref003","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3201\/eid1705.101939","article-title":"Probable non-vector-borne transmission of Zika virus, Colorado, USA","volume":"17","author":"BD Foy","year":"2011","journal-title":"Emerging infectious diseases"},{"key":"pntd.0008730.ref004","doi-asserted-by":"crossref","first-page":"i3416","DOI":"10.1136\/bmj.i3416","article-title":"Zika congenital syndrome is seen in infants whose mothers had asymptomatic infection","volume":"353","author":"M McCarthy","year":"2016","journal-title":"Bmj"},{"key":"pntd.0008730.ref005","unstructured":"Centers for Disease Control and Prevention. Zika virus: microcephaly & other birth defects 2018 [updated March 1, 2018August 9, 2018]. Available from: https:\/\/www.cdc.gov\/zika\/healtheffects\/birth_defects.html."},{"issue":"6283","key":"pntd.0008730.ref006","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1126\/science.aaf5036","article-title":"Zika virus in the Americas: Early epidemiological and genetic findings","volume":"352","author":"NR Faria","year":"2016","journal-title":"Science"},{"key":"pntd.0008730.ref007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijid.2016.02.001","article-title":"Rapid spread of Zika virus in the Americas\u2014Implications for public health preparedness for mass gatherings at the 2016 Brazil Olympic Games.","volume":"44","author":"E Petersen","year":"2016","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases."},{"issue":"1","key":"pntd.0008730.ref008","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4269\/ajtmh.16-0049","article-title":"Zika Virus disease in travelers returning to the United States, 2010\u20132014.","volume":"95","author":"MJ Hennessey","year":"2016","journal-title":"The American journal of tropical medicine and hygiene."},{"issue":"4","key":"pntd.0008730.ref009","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","volume":"11","author":"R Perera","year":"2008","journal-title":"Current opinion in microbiology"},{"issue":"1","key":"pntd.0008730.ref010","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/s41467-018-07008-0","article-title":"Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model.","volume":"9","author":"MJ Bailey","year":"2018","journal-title":"Nat Commun."},{"issue":"6284","key":"pntd.0008730.ref011","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 A resolution cryo-EM structure of Zika virus","volume":"352","author":"D Sirohi","year":"2016","journal-title":"Science"},{"issue":"2","key":"pntd.0008730.ref012","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nsmb.3352","article-title":"Structure of the immature Zika virus at 9 A resolution.","volume":"24","author":"VM Prasad","year":"2017","journal-title":"Nature structural & molecular biology."},{"issue":"5","key":"pntd.0008730.ref013","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody","volume":"19","author":"L Dai","year":"2016","journal-title":"Cell host & microbe"},{"issue":"1","key":"pntd.0008730.ref014","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00055-16","article-title":"The antigenic structure of Zika virus and its relation to other flaviviruses: Implications for infection and immunoprophylaxis.","volume":"81","author":"FX Heinz","year":"2017","journal-title":"Microbiology and molecular biology reviews: MMBR"},{"issue":"suppl_10","key":"pntd.0008730.ref015","doi-asserted-by":"crossref","first-page":"S935","DOI":"10.1093\/infdis\/jix515","article-title":"Zika Virus Structure, Maturation, and Receptors","volume":"216","author":"D Sirohi","year":"2017","journal-title":"J Infect Dis"},{"key":"pntd.0008730.ref016","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.virol.2017.12.032","article-title":"The Zika virus envelope protein glycan loop regulates virion antigenicity","volume":"515","author":"L Goo","year":"2018","journal-title":"Virology"},{"issue":"2","key":"pntd.0008730.ref017","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4049\/jimmunol.99.2.291","article-title":"Dengue virus identification by the plaque reduction neutralization test","volume":"99","author":"PK Russell","year":"1967","journal-title":"Journal of immunology"},{"issue":"6","key":"pntd.0008730.ref018","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/382280","article-title":"Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.","volume":"189","author":"TP Endy","year":"2004","journal-title":"J Infect Dis"},{"issue":"4","key":"pntd.0008730.ref019","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/CMR.3.4.376","article-title":"The dengue viruses","volume":"3","author":"EA Henchal","year":"1990","journal-title":"Clinical microbiology reviews"},{"issue":"5","key":"pntd.0008730.ref020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4269\/ajtmh.2009.08-0625","article-title":"Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance.","volume":"81","author":"SJ Thomas","year":"2009","journal-title":"The American journal of tropical medicine and hygiene"},{"key":"pntd.0008730.ref021","article-title":"Report of a collaborative study to assess the suitability of candidate reference material to serve as the first WHO reference reagent dengue virus antibody and to standardize the neutralization test for dengue viruses.","author":"M Ferguson","year":"2005"},{"issue":"11","key":"pntd.0008730.ref022","doi-asserted-by":"crossref","first-page":"e27252","DOI":"10.1371\/journal.pone.0027252","article-title":"Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes.","volume":"6","author":"K Mattia","year":"2011","journal-title":"PLoS One."},{"issue":"6","key":"pntd.0008730.ref023","doi-asserted-by":"crossref","first-page":"e1002111","DOI":"10.1371\/journal.ppat.1002111","article-title":"A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.","volume":"7","author":"KA Dowd","year":"2011","journal-title":"PLoS pathogens."},{"issue":"1","key":"pntd.0008730.ref024","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2008.08.021","article-title":"Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation","volume":"381","author":"C Ansarah-Sobrinho","year":"2008","journal-title":"Virology"},{"issue":"1","key":"pntd.0008730.ref025","doi-asserted-by":"crossref","first-page":"16509","DOI":"10.1038\/s41598-018-34735-7","article-title":"Purified inactivated Zika vaccine candidates afford protection against lethal challenge in mice","volume":"8","author":"WR Baldwin","year":"2018","journal-title":"Sci Rep"},{"key":"pntd.0008730.ref026","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ebiom.2017.12.010","article-title":"Passive transfer of immune sera induced by a Zika virus-like particle vaccine protects AG129 mice against lethal Zika virus challenge.","volume":"27","author":"D Espinosa","year":"2018","journal-title":"EBioMedicine."},{"issue":"3pt2","key":"pntd.0008730.ref027","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/trf.14041","article-title":"First cases of Zika virus-infected US blood donors outside states with areas of active transmission","volume":"57","author":"PC Williamson","year":"2017","journal-title":"Transfusion"},{"issue":"46","key":"pntd.0008730.ref028","doi-asserted-by":"crossref","first-page":"18662","DOI":"10.1073\/pnas.1310962110","article-title":"Atomic-level functional model of dengue virus Envelope protein infectivity","volume":"110","author":"EA Christian","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pntd.0008730.ref029","doi-asserted-by":"crossref","first-page":"e00873","DOI":"10.1128\/mBio.00873-13","article-title":"The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.","volume":"4","author":"SA Smith","year":"2013","journal-title":"mBio"},{"issue":"2","key":"pntd.0008730.ref030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"W Dejnirattisai","year":"2015","journal-title":"Nature immunology"},{"issue":"8","key":"pntd.0008730.ref031","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124588","article-title":"Human antibody response to Zika targets type-specific quaternary structure epitopes","volume":"4","author":"MH Collins","year":"2019","journal-title":"JCI insight"},{"issue":"7633","key":"pntd.0008730.ref032","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"G Sapparapu","year":"2016","journal-title":"Nature"},{"issue":"24","key":"pntd.0008730.ref033","doi-asserted-by":"crossref","first-page":"14364","DOI":"10.1128\/JVI.01943-14","article-title":"Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy","volume":"88","author":"RH Fong","year":"2014","journal-title":"Journal of virology"},{"issue":"3","key":"pntd.0008730.ref034","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/emmm.201303404","article-title":"A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface","volume":"6","author":"G Fibriansah","year":"2014","journal-title":"EMBO molecular medicine"},{"issue":"1","key":"pntd.0008730.ref035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JVI.02273-12","article-title":"Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop","volume":"87","author":"JM Costin","year":"2013","journal-title":"Journal of virology"},{"issue":"1","key":"pntd.0008730.ref036","doi-asserted-by":"crossref","first-page":"e0171148","DOI":"10.1371\/journal.pone.0171148","article-title":"Zika virus tissue and blood compartmentalization in acute infection of rhesus macaques","volume":"12","author":"LL Coffey","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pntd.0008730.ref037","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.12323","article-title":"A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes","volume":"143","author":"E Davidson","year":"2014","journal-title":"Immunology"},{"issue":"20","key":"pntd.0008730.ref038","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1021\/ja900186n","article-title":"Atomic-level mapping of antibody epitopes on a GPCR","volume":"131","author":"C Paes","year":"2009","journal-title":"Journal of the American Chemical Society"},{"issue":"7","key":"pntd.0008730.ref039","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20021840","article-title":"DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells.","volume":"197","author":"B Tassaneetrithep","year":"2003","journal-title":"The Journal of experimental medicine"},{"issue":"17","key":"pntd.0008730.ref040","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1128\/JVI.00354-15","article-title":"Biology of Zika virus infection in human skin cells","volume":"89","author":"R Hamel","year":"2015","journal-title":"Journal of virology"},{"issue":"2","key":"pntd.0008730.ref041","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"JH Zhang","year":"1999","journal-title":"Journal of biomolecular screening"},{"issue":"7614","key":"pntd.0008730.ref042","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika-dengue virus antibody cross-neutralization","volume":"536","author":"G Barba-Spaeth","year":"2016","journal-title":"Nature"},{"issue":"4","key":"pntd.0008730.ref043","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01123-16","article-title":"Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus.","volume":"7","author":"JA Swanstrom","year":"2016","journal-title":"mBio"},{"key":"pntd.0008730.ref044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2017.04.031","article-title":"Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies","volume":"508","author":"E Willis","year":"2017","journal-title":"Virology"},{"issue":"5","key":"pntd.0008730.ref045","article-title":"Zika virus is not uniquely stable at physiological temperatures compared to other flaviviruses.","volume":"7","author":"L Goo","year":"2016","journal-title":"mBio."},{"issue":"7603","key":"pntd.0008730.ref046","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature17994","article-title":"Structure of the thermally stable Zika virus","volume":"533","author":"VA Kostyuchenko","year":"2016","journal-title":"Nature"},{"issue":"1","key":"pntd.0008730.ref047","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virol.2005.10.030","article-title":"A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection","volume":"346","author":"TC Pierson","year":"2006","journal-title":"Virology"},{"key":"pntd.0008730.ref048","first-page":"87","article-title":"Mechanisms of virus neutralization by antibody","volume":"260","author":"PJ Klasse","year":"2001","journal-title":"Current topics in microbiology and immunology"},{"key":"pntd.0008730.ref049","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41541-019-0135-3","article-title":"Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibody.","volume":"4","author":"G Mattiuzzo","year":"2019","journal-title":"NPJ Vaccines."},{"issue":"9","key":"pntd.0008730.ref050","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"W Dejnirattisai","year":"2016","journal-title":"Nature immunology"},{"issue":"6334","key":"pntd.0008730.ref051","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"SV Bardina","year":"2017","journal-title":"Science"},{"issue":"12","key":"pntd.0008730.ref052","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1038\/cti.2016.72","article-title":"Dengue virus antibodies enhance Zika virus infection","volume":"5","author":"LM Paul","year":"2016","journal-title":"Clin Transl Immunology"},{"issue":"20","key":"pntd.0008730.ref053","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/emboj.2009.245","article-title":"Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody","volume":"28","author":"MV Cherrier","year":"2009","journal-title":"EMBO J"},{"issue":"1","key":"pntd.0008730.ref054","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1073\/pnas.1812055115","article-title":"Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies","volume":"116","author":"R Raut","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pntd.0008730.ref055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1073\/pnas.1819607116","article-title":"Insights from direct studies on human dengue infections","volume":"116","author":"SB Halstead","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pntd.0008730.ref056","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.celrep.2016.07.049","article-title":"Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype","volume":"16","author":"KA Dowd","year":"2016","journal-title":"Cell reports"},{"key":"pntd.0008730.ref057","unstructured":"US FDA\u2014Emergency Use Authorizations 2019 [updated July 7, 2019; cited 2019 July 8]. Available from: https:\/\/www.fda.gov\/medical-devices\/emergency-situations-medical-devices\/emergency-use-authorizations."},{"key":"pntd.0008730.ref058","unstructured":"CDC\u2014Testing & Diagnosis for Zika Virus 2019 [updated 2019; cited 2019 July 9]. Available from: https:\/\/www.cdc.gov\/pregnancy\/zika\/testing-follow-up\/testing-and-diagnosis.html."},{"issue":"1","key":"pntd.0008730.ref059","doi-asserted-by":"crossref","first-page":"16160","DOI":"10.1038\/s41598-017-16475-2","article-title":"Characterization of large and small-plaque variants in the Zika virus clinical isolate ZIKV\/Hu\/S36\/Chiba\/2016.","volume":"7","author":"F Kato","year":"2017","journal-title":"Sci Rep."},{"issue":"11","key":"pntd.0008730.ref060","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/JCM.00827-07","article-title":"Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization","volume":"45","author":"AA Kraus","year":"2007","journal-title":"Journal of clinical microbiology"},{"issue":"1","key":"pntd.0008730.ref061","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.2008.79.115","article-title":"Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies","volume":"79","author":"JR Putnak","year":"2008","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"1","key":"pntd.0008730.ref062","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4269\/ajtmh.2009.80.61","article-title":"An automated Dengue virus microneutralization plaque assay performed in human Fc{gamma} receptor-expressing CV-1 cells","volume":"80","author":"WW Rodrigo","year":"2009","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"11","key":"pntd.0008730.ref063","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.celrep.2015.11.043","article-title":"Neutralizing monoclonal antibodies block chikungunya virus entry and release by targeting an epitope critical to viral pathogenesis","volume":"13","author":"J Jin","year":"2015","journal-title":"Cell reports"},{"issue":"5","key":"pntd.0008730.ref064","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cell.2015.10.050","article-title":"Broadly neutralizing alphavirus antibodies bind an epitope on E2 and inhibit entry and egress","volume":"163","author":"JM Fox","year":"2015","journal-title":"Cell"},{"issue":"4","key":"pntd.0008730.ref065","doi-asserted-by":"crossref","first-page":"e1004072","DOI":"10.1371\/journal.ppat.1004072","article-title":"Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement.","volume":"10","author":"MA Edeling","year":"2014","journal-title":"PLoS pathogens."}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T12:48:41Z","timestamp":1697114921000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0008730"}},"subtitle":[],"editor":[{"given":"Aaron C.","family":"Brault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":65,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0008730","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.21.047241","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]}}}